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The purpose of this study was to investigate psychosocial stress in a large sample of cancer patients using an expert rating scale.
Specific aims were to analyse the relevance of setting variables (type of clinic, contact initiative, therapy) and gender. A total of 6365
patients were assessed in 105 institutions. Univariate and multivariate statistical analysis of setting variables indicated that patients
treated in palliative care settings showed highest distress scores compared to patients recruited from hospitals and outpatient clinics
(Po0.001). Significant differences were also found for contact initiative (Po0.001); lowest distress was found in patients who were
recruited by routine contact. Patients who asked for psychosocial support or who were recruited by the medical staff showed the
highest distress scores. The analysis of therapy groups showed that patients receiving radiotherapy or surgery were not more
distressed than patients without therapy. The most distressing treatment was chemotherapy. Gender had differential effects on clinic
type (Po0.001) and contact initiative (Po0.001) but not on treatment and diagnosis. Expert rating scales are an important
complement for self-assessment questionnaires to evaluate psychological distress of cancer patients in psychosocial studies as well as
in routine medical care.
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The burden of cancer patients is well documented. Around 30% of
all patients show psychosocial distress (Ibbotson et al, 1994; Ford
et al, 1995; Van’t Spijker et al, 1997; Payne et al, 1999; Ha ¨rter et al,
2001; Zabora et al, 2001; Herschbach et al, 2004a; Bultz and
Carlson, 2006; Sellick and Edwardson, 2007). However, prevalence
rates depend on the way we define and assess distress. We may
examine the prevalence of mental disorders with standardised
interviews (Ha ¨rter et al, 2001) or with questionnaires such as the
Brief Symptom Inventory (Derogatis, 1993) or the Hospital
Anxiety and Depression Scale (Zigmond and Snaith, 1983; Sellick
and Edwardson, 2007). We also use global health scales (General
Health Questionnaire; Goldberg and Williams, 1988), cancer-
specific distress scales (Roth et al, 1998; Herschbach et al, 2004a),
and quality-of-life inventories that are cancer specific (EORTC
Quality of Life Questionnaire; Aaronson and the EORTC QoL-
study-group, 1991; Functional Assessment of Cancer Therapy;
Cella et al, 1993) or generic (Spilker, 1990).
Till today, no expert rating scale focused specifically on
psychosocial distress in cancer patients. The only existing rating
scales are the Karnofsky-Index (Karnofsky et al, 1948) and
Spitzer-Index (Spitzer et al, 1981), which assess physical function-
ing. The first expert rating scale that assesses psychological
distress of cancer patients has recently been developed, the Basic
Documentation for Psycho-Oncology (PO-Bado) (Herschbach
et al, 2004b; Knight et al, 2008). This is an instrument applicable
for all types and stages of cancer. The PO-Bado does not provide
psychiatric diagnoses; however, it enables health-care profes-
sionals in all settings to carry out a disease-specific and
standardised assessment of distress as a basis for decisions and
appropriate interventions (Knight et al, 2008).
The use of expert rating scales has some advantages compared
to self-assessment questionnaires. First, they allow one to take the
overall impression of the patient into account, including non-
verbal behaviour, and to examine aspects of illness experience that
are not assessed by self-assessment questionnaires, such as denial.
It is defined as an ‘y adaptive strategy to protect against
overwhelming events and feelings’ (Vos and de Haes, 2007) and a
very important and frequent coping strategy in the illness
experience. Second, expert rating scales can be used for patients
who are unable to answer questionnaires due to mental or physical
problems.
The purpose of this paper is to analyse distress of cancer
patients on the basis of an expert rating. We were particularly
interested in the relevance of setting variables (type of hospital,
contact initiative, and type of treatment) and gender for the
psychosocial stress profile. Furthermore, the influence of diagnosis
on psychosocial stress was examined.
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Participants
The total sample included 6365 cancer patients who were treated
and assessed between 2003 and 2006. Among them, 4743 patients
were recruited from 25 hospitals, 6 rehabilitation clinics, and 4
outpatient clinics. An additional 1613 patients were recruited from
an ongoing study on palliative care including 42 palliative care
wards, 6 cancer wards, 7 hospices, and 15 outpatient clinics
(HOPE-study; Lindena et al, 2005).
Procedure
Patients were recruited in three different ways: they asked for
psychosocial support themselves, they were contacted by doctors
and nurses, or they were recruited through routine contact. The
PO-Bado interviews and ratings were conducted once at the
beginning of medical treatment by clinical psychologists and
doctors (n¼58) who received a manual and an interview
guideline. The manual gives detailed definitions of each item and
criteria for the item ratings. The interview guideline includes
instructions for a structured assessment and sample questions for
each item.
Measures
The PO-Bado assesses the subjective cancer-related experience of
the patient within the last 3 days. The interview takes about
20–30min. It consists of the two dimensions physical and
psychological distress. The physical dimension contains four
items: limitations of everyday activities, fatigue, pain, and one
item for other physical complaints. The psychological dimension
has eight items: anxiety/worries, depression/grief, helplessness,
shame/loss of self-esteem, mood swings, sleep disturbance,
cognitive impairment, and other psychological distress. Each item
is rated on a five-point Likert scale from 0 (not at all distressing) to
5 (very much distressing), indicating how much the patient suffers
subjectively from these illness aspects. Three scores can be
evaluated, a physical score (score for 0–16), a psychological
distress score (0–32), and a total score (0–48). Additionally,
patient’s socio-demographic and medical characteristics as well as
current treatments are documented.
The psychometric evaluation (Knight et al, 2008) showed
satisfactory results for internal consistency with Cronbach’s a
coefficient of 0.70 for the physical distress items and a¼0.85 for
the psychological distress items. Inter-rater reliability (intraclass
correlation coefficient) varied between 0.79 and 0.85 for the
somatic items and between 0.75 and 0.90 for the psychological
items. For convergent validity, Spearman’s rank correlation
coefficients were calculated for the QSC (Questionnaire on Stress
in Cancer Patients QSC R 23 – revised version; Herschbach et al,
2004a) and the HADS (Hospital Anxiety and Depression Scale;
Zigmond and Snaith, 1983) and showed substantial correlations
with the PO-Bado. The analyses of the discriminant validity
demonstrated the ability of the PO-Bado to differentiate patient
groups according to gender, disease status, type of treatment, and
functional status.
Data analysis
Group differences of PO-Bado distress scores (total scores) were
investigated with t-tests and F-tests. To investigate the effects of
gender, clinical setting variables (type of clinic, contact initiative,
therapy), and diagnoses on distress scores, four two-factor
analyses of variance were conducted for type of clinic, contact
initiative, therapy, and diagnoses as the first factors and with
gender as the second factor. Type III sums of squares were used.
The results of ANOVA for each independent variable are
reported first, followed by the mean distress scores for males and
females. To account for multiple comparisons, P-values were
multiplied by the number of tests when appropriate.
According to the large sample size, statistical significance was
assumed at Po0.01. All statistical analyses were carried out with
the Statistical Package for Social Sciences (Version 14.0).
RESULTS
First, the characteristics of the sample will be described, followed
by the presentation of single stress items for males and females.
Second, distress patterns for males and females in different settings
will be investigated, followed by the analysis of distress in males
and females in the diagnostic subgroups.
Sample
The total sample included 6365 cancer patients. Table 1 shows the
demographic characteristics of the sample for males and females.
Of the total sample, 66% were females, with a mean age of 59.5
years (s.d. 14.0). Seventy-one per cent of the patients had a partner.
The largest proportion of patients was on sick leave (30%) or
retired (45%).
Medical data are presented in Table 2. The most frequent
diagnoses of the patients were breast cancer (34%), haematological
neoplasias (12%), and tumours of the gastrointestinal tract (18%);
6% of the sample had cancer of unknown cause, rare, or other
cancer diagnoses. The most frequent diagnoses for men were
tumours of the gastrointestinal tract (26%) and haematological
neoplasias (19%). For women, breast cancer (52%), gynaecological
carcinomas (12%), and tumours of the gastrointestinal tract (12%)
were the most frequent.
Nearly half of the total sample (43%) had metastases and 21%
had relapses in their clinical course. The mean duration of cancer
Table 1 Demographic characteristics of patients
Male Female Total
N % N % N %
2177 34 4162 66 6356 100
Age, mean (s.d.)
Years 60.1 (14.3) 59.2 (13.8) 59.5 (14.0)
Range 18–98 16–99 16–99
Age groups
o40 years 229 11 396 10 627 10
41–50 years 249 12 746 18 997 16
51–60 years 429 20 951 23 1385 22
61–70 years 714 33 1133 28 1849 30
470 years 519 24 890 22 1413 22
With partner
a
Yes 1128 79 2284 69 3412 71
Employment
a
Employed 80 6 330 10 410 9
Sick leave 456 32 942 28 1398 30
Retired 804 56 1355 41 2159 45
Homemaker 5 0 500 15 505 11
Unemployed 53 4 93 3 146 3
Other 35 2 89 3 124 2
aNot available for HOPE study patients.
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11% of patients had a disease duration of more than 5 years.
In terms of treatment within the last 2 months, 40% of the
patients had surgical treatments, 10% in combination with either
chemotherapy or radiotherapy or both therapies. Twenty-three per
cent received chemotherapy only and 13% of the sample received
chemotherapy in combination with surgery and/or radiotherapy.
Women received more surgeries and fewer chemotherapies than
men. Nineteen per cent of the sample had no treatment during the
last 2 months. In terms of ‘contact initiative’, 24% of the patients
asked for psychosocial support, 27% were contacted by doctors or
nurses, and 49% were recruited through routine contact. The
majority of patients were recruited from university and general
hospitals (68%), followed by patients from palliative care (26%).
Table 2 Medical characteristics of patients
Male Female Total
N % N % N %
Tumour site
Breast 8 0.4 2174 52 2182 34
ENT carcinomas 189 9 59 1 248 4
Haematological neoplasias 420 19 324 8 745 12
Upper gastrointestinal tract 289 13 250 6 540 9
Lower gastrointestinal tract 283 13 255 6 541 9
Gynaecological carcinomas 0 0 515 12 515 8
Respiratory tract 279 13 171 4 457 7
Male genito-urinary tumours 303 14 0 0 303 5
Urinary tract 91 4 69 2 160 3
Sarcomas 87 4 86 2 174 3
Skin cancer 41 2 46 1 87 1
CUP; rare diagnoses; others 187 9 213 5 404 6
Metastases 1087 50 1629 39 2716 43
State of disease
a
First occurrence 769 54 2198 66 2967 63
Recurrence 317 22 674 20 991 21
Second tumour 46 3 164 5 210 4
Remission 211 15 160 5 371 8
Unknown 90 6 111 3 201 4
Duration of illness, mean (s.d.)
a
Months 22.2 (42.5) 22.0 (49.6) 22.1 (47.7)
Range 1 month–38 years 1 month–41 years 1 month–41 years
Categories
o1 month 245 20 1224 40 1469 34
2–12 months 570 46 963 31 1533 36
1–5 years 300 24 538 18 838 19
45 years 132 11 337 11 469 11
Treatment during the last 2 months
a
Surgery 190 14 1234 38 1424 30
Chemotherapy 443 32 631 19 1074 23
Radiotherapy 62 4 83 3 145 3
Surgery+chemotherapy 37 3 139 4 176 4
Surgery+radiotherapy 52 4 155 5 207 4
Chemotherapy+radiotherapy 129 9 217 7 346 7
Surgery+chemotherapy+radiotherapy 27 2 49 1 76 2
Hormone therapy 6 0.4 119 4 125 3
Other therapies 93 7 143 4 236 5
No therapy 367 26 499 15 866 19
Contact initiative
a
Patient 276 19 883 27 1159 24
Medical staff 364 25 892 27 1256 27
Routine 793 55 1534 46 2327 49
Treatment setting
University hospital 840 39 1434 34 2274 36
General hospital 466 21 1595 38 2061 32
Rehabilitation clinic 118 5 233 6 351 6
Outpatient clinic 9 0.4 48 1 57 1
Outpatient palliative care 136 6 161 4 300 5
Palliative care ward 545 25 595 14 1150 18
Hospice 63 3 96 2 163 3
aNot available for HOPE-study patients.
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sPsychological distress
Figure 1 shows the mean distress score for the 12 single items for
males and females.
The distress pattern indicates a tendency for higher distress for
males in the physical dimension and for females in the
psychological dimension. The highest distress scores were ‘limita-
tions in everyday activities’ for males and ‘anxiety/worries’ for
females. All gender differences were significant with the exception
of ‘shame/loss of self-esteem’. The total distress score for the
sample is 17.03 (s.d. 9.53) with a significant difference between
males (16.55, s.d. 9.55) and females (17.25, s.d. 9.50; P¼0.005).
An ANOVA was conducted for type of clinic and gender as the
two independent factors and distress as the outcome variable. The
analysis revealed a significant main effects for type of clinic
(F¼124.45, Po0.001) and gender (women4men; F¼18.36,
Po0.001) with a significant interaction (F¼19.56, Po0.001).
Thus, distress for male and female patients differs according to the
type of clinic.
Table 3 shows the mean distress scores for male and female
patients within the different clinic types. Highest scores for the
total sample were found in patients treated in palliative care units
and hospices. The lowest scores were found in patients treated in
general hospitals. Comparisons of mean distress in various types
of clinics were conducted separately for men and women and
showed significant differences within males as well as within
women (Po0.001). Comparisons between males and females
within each type of clinic showed significantly higher scores in
women treated in university clinics and rehabilitation clinics.
The second ANOVA was conducted for contact initiative and
gender. It showed a significant main effect for contact initiative
(F¼329.45, Po0.001) and gender (women4men; F¼17.77,
Po0.001) with a significant interaction (F¼7.05, P¼0.001).
Distress scores in the three categories of contact initiative differed
significantly within males (Po0.001) and females (Po0.001)
(Table 4). Patients recruited by routine contact showed the lowest
distress scores; the highest distress scores were found for patients
who asked for psychosocial support. A comparison of distress
means between males and females within each category showed
that women report significantly higher distress in the category
patient initiative and routine contact (Po0.001). No significant
gender differences were found in patients who were recruited by
doctors and nurses.
In the investigation of the effect of therapies (within the last 2
months) on distress, the ANOVA revealed significant main effects
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Figure 1 Distress scores of PO-Bado single items for male (solid line) and female patients.
Table 3 Total distress scores for type of clinic
Male Female Total
Mean s.d. Mean s.d. Mean s.d. P*
University hospital 15.12 9.89 19.81 10.01 18.08 10.22 o0.001
General hospital 13.63 7.20 12.59 7.20 12.83 7.21 NS
Rehabilitation clinic 10.46 7.56 16.59 9.19 14.53 9.14 o0.001
Outpatient clinic 13.44 9.62 17.73 9.67 17.05 9.71 NS
Outpatient palliative care 19.78 10.30 20.21 8.59 20.15 9.46 NS
Palliative care ward 21.31 8.54 22.27 8.66 21.84 8.62 NS
Hospice 20.94 9.66 21.99 8.33 21.35 8.90 NS
*Significance for the differences between male and female patients within each type
of clinic; P-values corrected for multiple testing.
Table 4 Total distress scores for contact initiative
Male Female Total
Mean s.d. Mean s.d. Mean s.d. P*
Patient 16.86 8.63 19.46 9.74 18.84 9.55 o0.001
Medical staff 19.30 9.64 18.98 9.61 19.07 9.62 NS
Routine 11.02 7.33 12.44 7.49 11.95 7.46 o0.001
*Significance for differences between male and female patients within each category
of contact initiative; P-values corrected for multiple testing.
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F¼36.92, Po0.001), whereas there was no significant interaction.
Contrast analysis within ANOVA showed significant differences
between no treatment group and patients receiving chemotherapy
only, chemotherapy in combination with surgery and/or radio-
therapy, or ‘other therapies’.
Table 5 shows mean distress scores in different therapy
categories compared to the no treatment group stratified by
gender. The analysis revealed the following results for men:
patients with surgery showed the lowest scores similar to the no
treatment group followed by hormone therapy and radiotherapy.
The highest scores were reported by men with ‘other therapies’. In
women, a similar pattern emerged: surgery and radiotherapy
showed no difference compared to ‘no therapy’; highest distress
score was reported for ‘other therapy’.
Finally, the effect of diagnostic groups on psychosocial distress
was investigated in men and women. Significant main effects were
found for diagnosis (F¼11.28, Po0.001) and gender (women4
men; F¼11.06, P¼0.001), but there was no interaction effect.
Table 6 shows mean distress scores for males and females. In
males, the highest scores were found in patients with cancer of the
respiratory tract followed by haematological neoplasias; lowest
scores were reported by ENT carcinoma patients; overall
differences within men were significant, with Po0.001. Women
with carcinomas of the respiratory tract showed the highest
distress scores followed by gynaecological carcinomas; relatively
low scores were found in women with breast cancer, ENT
carcinomas, and skin cancer; overall differences were significant
in women as well, with Po0.001. Although women reported
slightly higher distress than men in every diagnostic group, none
of these differences were significant after controlling for multiple
comparisons.
DISCUSSION
This is the first study investigating psychooncological distress in a
large sample of cancer patients with a cancer-specific expert rating
scale. Most of the psychooncological literature is based on studies
assessing the prevalence of mental disorders (categorical
approach) (Derogatis, 1993; Ha ¨rter et al, 2001), quality-of-life
studies (Spilker, 1990; Cella et al, 1993), or studies using global or
specific distress questionnaires (dimensional approach) (Zabora
et al, 2001; Herschbach et al, 2004a; Bultz and Carlson, 2006). We
believe that cancer-specific distress measures have the highest
clinical relevance (for determining the need of support or planning
of psychotherapeutic interventions). Furthermore, the use of
expert rating scales has the advantage of examining aspects
of experience that are not assessed by self-assessment
questionnaires and that they can be used for patients who are
unable to answer questionnaires.
In this study, we investigated the expert-rated global distress
and analysed the relevance of three distress conditions: setting
variables, gender, and diagnosis.
Overall, female patients were more distressed than male
patients, which supports findings from previous research (Zabora
et al, 2001; Herschbach et al, 2004a; Bultz and Carlson, 2006).
Looking at the analysis in more detail, women reported higher
levels of distress in most of the psychological dimension whereas
men had higher distress scores in the physical dimension.
To analyse the relevance of the treatment setting for psycho-
social distress, the following variables were examined: type of
clinic, contact initiative, and type of treatment. Looking at the type
of clinic, patients receiving palliative treatment (outpatients care,
palliative care ward, and hospice) had the highest global distress
scores, which may be related to the severity of disease (somatic
comorbidity). Furthermore, there was a significant interaction
between type of clinic and gender. Thus, female patients were more
distressed than male patients in university and rehabilitation
clinics. A possible reason for this finding may be complex
confounding effects of diagnosis and stage of disease in these
settings.
Additionally, the way patients were selected to participate in this
study (initiated by the patient, by medical staff, or by routine
assessment) had a significant effect on psychological distress. As
Table 5 Total distress scores for male and female patients in subgroups of therapy compared to no treatment
Male Female Total
Mean s.d. P1* Mean s.d. P2* Mean s.d. P3*
No treatment 10.09 7.94 13.82 8.93 12.24 8.72 o0.001
Surgery 9.42 6.95 NS 13.33 8.50 NS 12.81 8.42 o0.001
Chemotherapy 18.44 8.72 o0.001 20.86 9.26 o0.001 19.86 9.11 o0.001
Radiotherapy 12.10 8.17 NS 16.45 9.46 NS 14.59 9.16 NS
Hormone therapy 11.17 5.88 NS 17.99 9.72 o0.001 17.66 9.66 NS
Other therapy 19.38 9.88 o0.001 22.04 9.78 o0.001 20.99 9.89 NS
Surgery+chemotherapy 18.46 9.66 o0.001 19.10 9.37 o0.001 18.97 9.41 NS
Surgery+radiotherapy 13.37 5.48 o0.001 14.21 7.28 NS 14.00 6.87 NS
Chemotherapy+radiotherapy 15.12 7.62 o0.001 16.51 8.12 o0.001 15.99 7.96 NS
Surgery+chemotherapy+radiotherapy 14.93 5.66 o0.001 19.76 8.47 o0.001 18.04 7.90 NS
*P1: difference between each therapy group and the non-treatment group within males; P2: difference between each therapy group and the non-treatment group within females;
P3: differences between male and female patients within each therapy group; *P-values corrected for multiple testing.
Table 6 Total distress scores for diagnostic subgroups
Male Female Total
Mean s.d. Mean s.d. Mean s.d. P*
Breast 16.00 10.39 15.70 9.22 15.72 9.24 NS
Gynaecological carcinomas 20.10 9.30 20.13 9.31
Respiratory tract 19.15 9.19 20.57 9.01 19.76 9.13 NS
Male genito-urinary tumours 15.16 9.70 15.13 9.68
Lower gastrointestinal tract 14.55 9.45 16.20 9.24 15.39 9.39 NS
ENT carcinomas 12.24 9.29 15.88 11.01 13.11 9.83 NS
Haematological neoplasias 18.33 8.63 19.25 9.15 18.74 8.86 NS
Skin cancer 15.66 9.24 16.30 9.37 16.00 9.26 NS
Sarcomas 16.54 10.32 19.56 9.87 18.03 10.15 NS
Urinary tract 16.37 10.16 18.30 9.86 17.21 10.05 NS
Upper gastrointestinal tract 17.92 9.45 19.43 9.05 18.61 9.29 NS
Others 16.43 9.48 18.48 10.33 17.58 10.03 NS
*Differences between male and female patients within diagnostic subgroups; P-values
corrected for multiple testing.
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sexpected, patients who were recruited through routine contact had
the lowest stress scores. Interestingly, only when patient contact
was initiated by the medical staff, there was no gender difference.
Otherwise, females showed higher levels of distress than males.
Obviously, gender is not a variable that has a major impact on the
distress assessment of the staff.
In terms of medical treatment, we compared single and
combined medical treatment procedures with ‘no therapy’. Thus,
receiving surgery or radiotherapy (within the last 2 months) is not
more distressing than having no treatment. This is also true for
men with regard to hormone therapy and for women with surgery
plus radiotherapy. Receiving no treatment may be much more
distressing. Highest distress was found in patients with ‘other
therapies’. Assuming that ‘other therapies’ are complementary or
experimental therapies, it is likely that those patients do not have
curative treatment options any more. Besides these therapies,
chemotherapy is the most distressing procedure. Combinations of
therapy such as radio-chemotherapy are not necessarily more
distressing than single intervention alone.
Looking at the role of diagnostic subgroups and gender, we
found significant main effects for diagnosis and gender but no
significant interaction. Patients with gynaecological carcinomas
and cancer of the respiratory tract reported the highest levels of
distress. In terms of gender, female patients were generally more
distressed than male patients but did not differ significantly within
the diagnostic subgroups.
Altogether, the study showed that type of treatment has an
important impact on psychological distress of cancer patients.
However, this does not imply that treatment in general is more
distressing than no treatment. Certain types of treatment (surgery,
hormone therapy, and radiotherapy) may be related to the hope of
survival and may therefore be associated with lower levels of
distress. This finding supports previous research on quality of life
indicating that objective illness and treatment variables are only
weakly correlated with the subjective illness experience
(Herschbach, 2002). The second major result refers to the role of
gender. The literature suggests that female cancer patients are
generally more distressed than male patients (Zabora et al, 2001;
Herschbach et al, 2004a). This suggestion is partly supported by the
current study, as females reported higher overall distress; however,
looking at the different dimensions of distress, we found that
females are more distressed than males only in terms of
psychological distress and not in terms of somatic distress. Relating
gender to diagnostic subgroups, we did not find any significant
gender differences.
There are some methodological limitations in our study that
should be mentioned. The sample included 6365 cancer patients
from a multicentre study including 105 institutions, and was
associated with the following problems.
First, patients were selected in three different ways: they asked
for psychosocial support, they were contacted by doctors or
nurses, or they were recruited through routine contact. Thus,
patients were recruited consecutively only for routine contact and
there may be a selection bias for the other two types of
recruitment.
Second, the main aim of our study was the influence of setting
variables and gender on psychosocial distress; we are aware that
the second aim, the importance of diagnosis, would not be
representative in its distribution across the sample.
Finally, it would be interesting to analyse the influence of staff
using the rating scale (discipline, job experience, interviewer
training, etc.); however, owing to the large and heterogenic sample,
this information is not available and should be the subject of future
research.
We believe that there are good reasons to use expert rating
scales; some of the new and unexpected findings of this study may
be based on the use of this scale.
ACKNOWLEDGEMENTS
This study was supported by the German Cancer Aid (Deutsche
Krebshilfe e.V.). We thank the participating clinics and also the
colleagues for supporting this study.
REFERENCES
Aaronson NK, the EORTC QoL-study-group (1991) The EORTC core
quality of life questionnaire. In Effect of Cancer on QoL, Osoba D (ed) pp
185–203. CRC Press: Vancouver
Bultz BD, Carlson LE (2006) Emotional distress: the sixth vital sign–future
directions in cancer care. Psycho-Oncology 15: 93–95
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M,
Yellen SB, Winicour P, Brannon J (1993) The functional assessment of
cancer therapy scale: development and validation of the general measure.
J Clin Oncol 11(3): 570–579
Derogatis LR (1993) The Brief Symptom Inventory (BSI): Administration,
Scoring and Procedures Manual. MN National Computer Systems:
Minneapolis, MN
Ford S, Lewis S, Fallowfield L (1995) Psychological morbidity in newly
referred patients with cancer. J Psychosom Res 39: 193–202
Goldberg D, Williams P (1988) A User’s Guide to the General Health
Questionnaire. NFER-Nelson: Windsor
Ha ¨rter M, Reuter K, Aschenbrenner A, Schretzmann B, Marschner N,
Hasenburg A, Weis J (2001) Psychiatric disorders and associated factors
in cancer: results of an interview study with patients in inpatient,
rehabilitation and outpatient treatment. Eur J Cancer 37(11): 1385–1393
Herschbach P, Brandl T, Knight L, Keller M (2004b) Einheitliche
Beschreibung des subjektiven Befindens von Krebskranken. Entwicklung
einer psychoonkologischen Basisdokumentation (PO-Bado). Deutsches
A ¨rzteblatt 101(12): 799–802
Herschbach P, Keller M, Knight L, Brandl T, Huber B, Henrich G, Marten-
Mittag B (2004a) Psychological problems of cancer patients: a cancer
distress screening with a cancer-specific questionnaire. Br J Cancer 91:
504–511
Herschbach P (2002) Das ‘Zufriedenheitsparadox’ in der Lebensqualita ¨ts-
forschung – wovon ha ¨ngt unser Wohlbefinden ab? Psychother Psychosom
Med Psychol 52: 141–150
Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L (1994) Screening
for anxiety and depression in cancer patients: the effects of disease and
treatment. Eur J Cancer 30A(1): 37–40
Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH (1948) The use of
the nitrogen mustards in the palliative treatment of carcinoma. Cancer 1:
634–656
Knight L, Mussell M, Brandl T, Herschbach P, Marten-Mittag B, Treiber M,
Keller M (2008) Development and psychometric evaluation of the basic
documentation for Psycho-Oncology (PO-Bado), a tool for standardized
assessment of cancer patients. J Psychosom Res 64(4): 373–381
Lindena G, Nauck F, Bausewein C, Neuwo ¨hner K, Heine O, Schulenberg D,
Radbruch L (2005) Qualita ¨tssicherung in der Palliativmedizin –
Ergebnisse der Kerndokumentation 1999–2002. Z Evid Fortbild Qual
Gesundh Wesen 99: 555–565
Payne DK, Hoffman RG, Theodoulou M, Dosik M, Massie MJ (1999)
Screening for anxiety and depression in women with breast cancer.
Psychosomatics 40: 64–69
Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher H,
Holland JC (1998) Rapid screening of psychologic distress in men with
prostate carcinoma. A pilot study. Cancer 82(10): 1904–1908
Sellick SM, Edwardson AD (2007) Screening new cancer patients for
psychological distress using the hospital anxiety and depression scale.
Psycho-Oncology 16: 534–542
Spilker B (ed) (1990) Quality of Life Assessments in Clinical Trials. Raven
Press: New York
Psychological distress in cancer patients
P Herschbach et al
42
British Journal of Cancer (2008) 99(1), 37–43 & 2008 Cancer Research UK
C
l
i
n
i
c
a
l
S
t
u
d
i
e
sSpitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R, Battista
RN, Catchlove BR (1981) Measuring the quality of life of cancer patients.
A concise QL-Index for use by physicians. J Chron Dis 34: 585–597
Van’t Spijker A, Trijsburg RW, Duivenvoorden HJ (1997) Psychological
sequelae of cancer diagnosis: a meta-analytical review of 58 studies after
1980. Psychosom Med 59: 280–293
Vos MS, de Haes JCJM (2007) Denial in cancer patients, an explorative
review. Psycho-Oncology 16: 12–25
Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The
prevalence of psychological distress by cancer site. Psycho-Oncology 10: 19–28
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale.
Acta Psychiatr Scand 67: 361–370
Psychological distress in cancer patients
P Herschbach et al
43
British Journal of Cancer (2008) 99(1), 37–43 & 2008 Cancer Research UK
C
l
i
n
i
c
a
l
S
t
u
d
i
e
s